Adela, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
Adela, Inc. is a biotechnology company based in Foster City, California, focused on blood-based cancer diagnostics for minimal residual disease and multi-cancer early detection. It aims to accelerate diagnosis and improve cancer management by capturing broad, biologically relevant genomic information from the methylome in blood, expanding the potential to detect cancer signals beyond narrower genomic targets. The company promotes a tissue-free approach that provides universal access to MRD testing for patients by removing dependence on tumor tissue. Its tests are clinically validated for two applications: predicting and surveilling recurrence in head and neck cancer, and monitoring immunotherapy response in advanced cancer. Its market includes clinicians and patients seeking MRD monitoring and early cancer detection, especially where tumor tissue is unavailable or difficult to obtain. Operating in the biotechnology research sector, Adela emphasizes genome-wide methylome enrichment to inform treatment decisions and disease monitoring through blood tests. In March 2026, Adela announced the launch of a tissue-free MRD test for head and neck cancer, marking a step toward commercialization.
1-888-653-2347 
support@leadiq.com 
